摘要
目的:为改进我国药品第二医药用途发明的审查给出建议。方法:回溯瑞士型权利要求在欧洲的起源、发展和终结,探讨瑞士型权利要求的本质,从审查理论和我国制药工业发展、临床应用的现实角度对瑞士型权利要求的给药特征进行分析。结果:对第二医药用途发明的给药特征进行保护是世界发展趋势,改进给药特征的创造性劳动应予以保护。结论:建议加大我国瑞士型权利要求的保护强度,激励我国医药工业的发展。
Objective:To provide suggestions for improving the examination of second medical use inventions of drugs in China.Method:Tracing back the origin,development,and termination of Swiss type claims in Europe,exploring the essence of Swiss type claims,and analyzing the drug administration characteristics of Swiss type claims from the perspectives of review theory,China’s pharmaceutical industry development and clinical reality.Results:The protection of the drug delivery characteristics of the invention for the second medical use is a global development trend,and creative labor to improve drug delivery characteristics should be protected.Conclusion:In order to stimulate the development of China’s pharmaceutical industry,it is recommended to strengthen the protection of Swiss-type claims in China.
作者
赵建民
梁媛
ZHAO Jianmin;LIANG Yuan(Patent Examination Cooperation(Tianjin)Center of the Patent Ofice,Tianjin 300304,China;Tianjin First Central Hospital,Tianjin 300192,China)
出处
《药学与临床研究》
2024年第1期85-89,共5页
Pharmaceutical and Clinical Research
关键词
瑞士型权利要求
给药特征
可专利性
仿制药
Swiss-type claim
Administration characteristics
Patentability
Generics
